Keyphrases
Functional Epitope
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Site-directed mutagenesis
100%
Ligand Binding
100%
Urokinase-type Plasminogen Activator
100%
Alanine Scanning
16%
Energetic Impact
16%
Protein Domain
16%
Site Substitution
16%
Photoaffinity Labeling
16%
In Cancer
16%
Epitope
16%
Alanine Substitution
16%
Multi-domain
16%
Surface Plasmon Resonance
16%
Structural Perturbation
16%
Four Positions
16%
Receptor Binding
16%
Chemical Cross-linking
16%
Cancer Therapy
16%
Monoclonal Antibody
16%
Site-directed
16%
Ly-6
16%
Binding Kinetics
16%
Glycolipids
16%
3D Structure
16%
Chemical Modification
16%
Receptor-interacting Protein Kinase 1 (RIPK1)
16%
Rational Drug Design
16%
Free Energy
16%
Neuroscience
Urokinase Receptor
100%
Urokinase
100%
Epitope
100%
Receptor
100%
Ligand Binding
100%
Site-Directed Mutagenesis
100%
Alanine
50%
Protein Tertiary Structure
16%
Monoclonal Antibody
16%
Binding Kinetics
16%
Glycolipid
16%
Receptor Binding
16%
Receptor Protein
16%
Arginine
16%
Energy Transfer
16%
Biochemistry, Genetics and Molecular Biology
Urokinase Receptor
100%
Site-Directed Mutagenesis
100%
Ligand Binding
100%
Urokinase
100%
Alanine
50%
Biochemistry
16%
Receptor Binding
16%
Protein Tertiary Structure
16%
Surface Plasmon Resonance
16%
Glycolipid
16%
Energy Transfer
16%
Conformation
16%
Binding Kinetics
16%
Cross-Link
16%
Photoaffinity Labeling
16%
Arginine
16%
Monoclonal Antibody
16%
Immunology and Microbiology
Urokinase Receptor
100%
Ligand Binding
100%
Site Directed Mutagenesis
100%
Epitope
100%
Alanine
50%
Conformation
16%
Energy Transfer
16%
Protein Tertiary Structure
16%
Surface Plasmon Resonance
16%
Receptor Binding
16%
Binding Kinetics
16%
Monoclonal Antibody
16%
Cross Linking
16%